Buy, Hold, Sell: CoreWeave AI Cloud Gamble for Investors
CoreWeave faces a split verdict as revenue surges and debt refinancing looms. The market must decide whether it becom...
Why Use Passive Investing For Retirement
Passive investing can simplify retirement saving by lowering costs and smoothing returns. Learn why this approach often suits long-term goals vs active strategies.
23,287 articles
Jensen Huang Sounds Eerily Like Buffett as AI Dip Buy Signal
NVIDIA CEO Jensen Huang positioned the latest AI stock pullback as a buying opportunity, a stance that reminds invest...
Nexstar CEO: Tech Swallowed Local News, TV Could Follow
Nexstar's chief executive warns that the era of local news funding through traditional ads may be ending. He says the...
Temasek’s Moving Into Power: CFO Shakeup Reshapes Strategy
Temasek unveils a sweeping leadership overhaul, elevating its CFO into a central strategic role as the group reorgani...
Bill Ackman and David Tepper Bet Big on Amazon This Week
A wave of billionaire fund managers are boosting Amazon bets as AI hype collides with a value play. Pershing Square, ...
Director Kash Patel Undisclosed Stock Raises Conflict
The FBI director disclosed a late Strategy stock purchase, prompting questions about STOCK Act timing and potential c...
Forget URA: This Pure-Miner Uranium ETF Surges 61%
A dedicated pure-miner uranium fund has jumped 61% this year, outpacing broader uranium plays. Analysts say the move ...
Citigroup This Year: Outperforming the Big Bank Stocks 2026
Citigroup is up about 14% year-to-date through mid-July 2026, outpacing Bank of America and Wells Fargo. AI-driven tr...
Cloud Capacity Sold Out Reshapes NVIDIA Blackwell Push
NVIDIA’s data-center momentum is accelerating as cloud capacity sold out tightens the AI compute market, pushing the ...
Economist Mohamed El-Erian Warns of Global Stagflation Risk
Global markets wobbled as renewed Middle East conflict raises the risk of stagflation. Economist Mohamed El-Erian war...
UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Rethinking Diversification: Where Blue-Chip Art Fits
As markets wobble in early 2026, blue-chip art is moving from galleries to mainstream portfolios. This piece explains...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status